Ioxilan

Radiographic Contrast Agent — VARIOUS

Key facts

Ioxilan is an ofm drug in the Radiographic Contrast Agent class catalogued in DrugCentral. It was first approved by the FDA in 1995. Its mechanism of action is classified as X-Ray Contrast Activity.

• Approval status: ofm (first approved 1995 by the FDA).
• Drug class: Radiographic Contrast Agent.
• Mechanism of action: X-Ray Contrast Activity.
• ATC code: V08AB12 (Watersoluble, nephrotropic, low osmolar X-ray contrast media).
• Molecular formula: C18H24I3N3O8; molecular weight 791.12 g/mol.

Mechanism & targets

• Mechanism of action (MoA): X-Ray Contrast Activity
• Established pharmacologic class: Radiographic Contrast Agent

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1995-12-21	FDA	—	GUERBET

ATC classification

ATC code	Therapeutic hierarchy
V08AB12	VARIOUS › CONTRAST MEDIA › X-RAY CONTRAST MEDIA, IODINATED › Watersoluble, nephrotropic, low osmolar X-ray contrast media

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Urticaria	62.8

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Ioxilan is on its molecule page.

• Molecular formula: C₁₈H₂₄I₃N₃O₈
• Molecular weight: 791.12 g/mol
• CAS number: —
• InChIKey: UUMLTINZBQPNGF-UHFFFAOYSA-N
• PubChem CID: 3743

CC(=O)N(CC(O)CO)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCCO)=C1I

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Ioxilan work?

Ioxilan is classified as X-Ray Contrast Activity.

When was Ioxilan first approved?

Ioxilan was first approved by the FDA in 1995.

What drug class does Ioxilan belong to?

Ioxilan is in the Radiographic Contrast Agent class.

What is the chemical formula of Ioxilan?

Ioxilan has the molecular formula C18H24I3N3O8 and a molecular weight of 791.12 g/mol.

Sources

• DrugCentral drug card 1473 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1201075 — compound record and bioactivity
• PubChem CID 3743 — chemical identifiers
• DrugBank DB09135 — drug record
• FDA UNII A4YJ7J11TG — substance identity
• DailyMed: FDA labels for Ioxilan — current prescribing information (label search)
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.